S
IONS icon

Seeyond’s Ionis Pharmaceuticals IONS Stock Holding History

Seeyond’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-33,852
Closed -$1.35M – 605
2021
Q2 		$1.35M Buy
33,852
+151
+0.4% +$5.91K 0.13% 257
2021
Q1 		$1.51M Buy
33,701
+7,757
+30% +$433K 0.15% 221
2020
Q4 		$1.47M Sell
25,944
-24,593
-49% -$1.23M 0.15% 229
2020
Q3 		$2.4M Buy
50,537
+13,979
+38% +$777K 0.26% 89
2020
Q2 		$2.15M Buy
36,558
+32,129
+725% +$1.79M 0.24% 101
2020
Q1 		$509K Sell
4,429
-34
-0.8% -$1.9K 0.07% 374
2019
Q4 		$270K Hold
4,463
– – 0.03% 504
2019
Q3 		$267K Buy
4,463
+2,648
+146% +$173K 0.03% 491
2019
Q2 		$117K Buy
+1,815
New +$128K 0.01% 596

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Seeyond's IONS Position: Q3 2021 in Review

Seeyond sold out of Ionis Pharmaceuticals (IONS) in Q3 2021, closing a stake of 33,852 shares — an estimated $1.35M sold.

Seeyond first reported a position in IONS in Q2 2019 and held it in 9 quarters. The position peaked at $2.4M in Q3 2020. 324 funds tracked by Wall St. Rank hold IONS as of Q3 2021.

  • Seeyond reported no remaining Ionis Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Seeyond sold 33,852 Ionis Pharmaceuticals shares in Q3 2021, an estimated $1.35M.
  • Seeyond first reported a position in Ionis Pharmaceuticals in Q2 2019 and held it in 9 quarters.
  • Seeyond's Ionis Pharmaceuticals position peaked at $2.4M in Q3 2020.
  • 324 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2021.

Based on Seeyond's 13F filing for Q3 2021, filed 12 Nov 2021.